MARCUZZI, Annalisa
 Distribuzione geografica
Continente #
NA - Nord America 5.374
AS - Asia 3.149
EU - Europa 1.525
SA - Sud America 693
AF - Africa 87
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 10.832
Nazione #
US - Stati Uniti d'America 5.262
SG - Singapore 1.268
CN - Cina 694
BR - Brasile 544
PL - Polonia 476
VN - Vietnam 420
HK - Hong Kong 311
IT - Italia 308
FR - Francia 154
DE - Germania 126
GB - Regno Unito 110
RU - Federazione Russa 96
ID - Indonesia 82
JP - Giappone 66
IN - India 64
AR - Argentina 59
UA - Ucraina 55
FI - Finlandia 50
BD - Bangladesh 48
TR - Turchia 48
MX - Messico 45
CA - Canada 39
ZA - Sudafrica 38
NL - Olanda 33
AT - Austria 23
IQ - Iraq 20
SE - Svezia 19
CO - Colombia 17
EC - Ecuador 16
ES - Italia 16
PK - Pakistan 16
CL - Cile 15
UZ - Uzbekistan 15
VE - Venezuela 14
MY - Malesia 13
AE - Emirati Arabi Uniti 11
IE - Irlanda 11
PH - Filippine 10
PY - Paraguay 10
SA - Arabia Saudita 9
BO - Bolivia 8
CZ - Repubblica Ceca 8
DO - Repubblica Dominicana 8
KE - Kenya 8
MA - Marocco 8
BE - Belgio 7
JM - Giamaica 7
LT - Lituania 7
TH - Thailandia 7
NP - Nepal 6
TN - Tunisia 6
AZ - Azerbaigian 5
EG - Egitto 5
SN - Senegal 5
UY - Uruguay 5
BA - Bosnia-Erzegovina 4
CR - Costa Rica 4
DZ - Algeria 4
IL - Israele 4
JO - Giordania 4
KG - Kirghizistan 4
KZ - Kazakistan 4
RO - Romania 4
TW - Taiwan 4
CH - Svizzera 3
CI - Costa d'Avorio 3
ET - Etiopia 3
KR - Corea 3
OM - Oman 3
PE - Perù 3
PS - Palestinian Territory 3
AL - Albania 2
AO - Angola 2
BY - Bielorussia 2
DK - Danimarca 2
GA - Gabon 2
GP - Guadalupe 2
GR - Grecia 2
GY - Guiana 2
HN - Honduras 2
HU - Ungheria 2
MD - Moldavia 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AU - Australia 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BW - Botswana 1
EU - Europa 1
GE - Georgia 1
GT - Guatemala 1
KH - Cambogia 1
KW - Kuwait 1
LB - Libano 1
LV - Lettonia 1
MN - Mongolia 1
NG - Nigeria 1
PA - Panama 1
PT - Portogallo 1
Totale 10.829
Città #
Ashburn 803
Fairfield 685
Singapore 672
Warsaw 472
San Jose 363
Woodbridge 355
Santa Clara 307
Hong Kong 305
Seattle 273
Beijing 267
Houston 263
Cambridge 239
Wilmington 207
Dallas 149
Ho Chi Minh City 140
Council Bluffs 102
Hanoi 100
Ann Arbor 85
Ferrara 78
Los Angeles 78
Lauterbourg 76
Princeton 73
Tokyo 62
New York 61
Jakarta 60
Chandler 59
São Paulo 55
Chicago 52
San Diego 47
Moscow 45
Shanghai 39
London 38
Munich 38
Jacksonville 35
Nuremberg 26
Orem 26
Helsinki 25
Mexico City 24
Rio de Janeiro 23
Milan 21
Buffalo 20
Dong Ket 20
Johannesburg 20
Haiphong 19
Atlanta 18
Montreal 18
Bologna 17
Brooklyn 17
Chennai 17
Denver 17
Jinan 17
Nanjing 17
Amsterdam 15
Boardman 15
Frankfurt am Main 15
Manchester 15
Stockholm 14
Tashkent 14
Da Nang 13
Poplar 13
Salt Lake City 13
Aprilia 12
Hải Dương 12
Izmir 12
Brasília 11
Changsha 11
Falls Church 11
Ankara 10
Boston 10
Boydton 10
Rome 10
Shenyang 10
Belo Horizonte 9
Campinas 9
Elk Grove Village 9
Istanbul 9
Mumbai 9
Paris 9
Redwood City 9
The Dalles 9
Turku 9
Assago 8
Baghdad 8
Dublin 8
Lappeenranta 8
Norwalk 8
Perugia 8
Toronto 8
Buenos Aires 7
Curitiba 7
Hebei 7
Hefei 7
Hounslow 7
Medellín 7
Mountain View 7
Phoenix 7
San Francisco 7
Santiago 7
Trieste 7
Vienna 7
Totale 7.512
Nome #
Antibodies reacting to mimotopes of Simian virus 40 large T antigen, the viral oncoprotein, in sera from children 418
Neuronal dysfunction associated with cholesterol deregulation 265
Cytokine levels in the serum of healthy subjects 228
Type I interferon-mediated autoinflammation due to DNase II deficiency 212
Pediatric patients with inflammatory bowel disease exhibit increased serum levels of proinflammatory cytokines and chemokines, but decreased circulating levels of macrophage inhibitory protein-1β, interleukin-2 and interleukin-17 211
Lovastatin dose-dependently potentiates the pro-inflammatory activity of lipopolysaccharide both in vitro and in vivo 210
To extinguish the fire from outside the cell or to shutdown the gas valve inside? Novel trends in anti-inflammatory therapies 210
Geranylgeraniol and Neurological Impairment: Involvement of Apoptosis and Mitochondrial Morphology 207
Curcumin anti-apoptotic action in a model of intestinal epithelial inflammatory damage 188
Two-gene mutation in a single patient: Biochemical and functional analysis for a correct interpretation of exome results 186
The complex interplay between lipids, immune system and interleukins in cardio-metabolic diseases 186
Autoinflammatory diseases and cytokine storms-imbalances of innate and adaptative immunity 174
A common genetic background could explain early-onset Crohn's disease 169
Cytokine profiles of women with vulvodynia: Identification of a panel of pro-inflammatory molecular targets 168
Putative modifier genes in mevalonate kinase deficiency 166
Metabolic Syndrome and Psoriasis: Pivotal Roles of Chronic Inflammation and Gut Microbiota 164
Alendronate, a double-edged sword acting in the mevalonate pathway 163
Comments on ''Geranylgeraniol--a new potential therapeutic approach to bisphosphonate associated osteonecrosis of the jaw" by Ziebart T et al. (2011) 158
Innovative target therapies are able to block the inflammation associated with dysfunction of the cholesterol biosynthesis pathway 156
Repositioning of Tak-475 in mevalonate kinase disease: Translating theory into practice 151
A comparative analysis of serologic parameters and oxidative stress in osteoarthritis and rheumatoid arthritis: reply to Mishra and colleagues 151
Role of vitamin D in the pathogenesis of atheromatosis 151
Human skin volatilome: a pleiotropic tool to study inflammatory skin conditions 150
Is autophagy an elective strategy to protect neurons from dysregulated cholesterol metabolism? 150
Altered germinal center reaction and abnormal B cell peripheral maturation in PI3KR1-mutated patients presenting with HIGM-like phenotype 149
Mitochondria-Targeted Antioxidants, an Innovative Class of Antioxidant Compounds for Neurodegenerative Diseases: Perspectives and Limitations 147
Clinical Genetic Testing of Periodic Fever Syndromes 146
Genistein exerts in vitro anti-inflammatory effects via NLRP3 modulation in a keratinocyte model 145
Natural isoprenoids are able to reduce inflammation in a mouse model of mevalonate kinase deficiency 144
Mevalonate kinase deficiency: therapeutic targets, treatments, and outcomes 144
Database tools in genetic diseases research 142
Comments to the editor concerning the paper entitled "Preclinical renal cancer chemopreventive efficacy of geraniol by modulation of multiple molecular pathways" Shiekh Tanveer Ahmad et al 141
Rapid recovery of postnivolumab vemurafenib-induced Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) syndrome after tocilizumab and infliximab administration 141
Block of the Mevalonate Pathway Triggers Oxidative and Inflammatory Molecular Mechanisms Modulated by Exogenous Isoprenoid Compounds 139
Ex vivo response to mucosal bacteria and muramyl dipeptide in inflammatory bowel disease 139
TRAIL administration down-modulated the acute systemic inflammatory response induced in a mouse model by muramyldipeptide or lipopolysaccharide 138
Mevalonate Kinase Deficiency and Neuroinflammation: Balance between Apoptosis and Pyroptosis 138
Lovastatin-induced apoptosis is modulated by geranylgeraniol in a neuroblastoma cell line 137
Acute Neurological Involvement after Donor Lymphocyte Infusion for Post-Transplant Viral Infection: The Same Pattern of Novel Cancer Immunotherapy-Related CNS Toxicity? 136
Convolvulus pluricaulis Choisy’s Extraction, Chemical Characterization and Evaluation of the Potential Effects on Glycaemic Balance in a 3T3-L1 Adipocyte Cell Model 134
The effect of clodronate on a mevalonate kinase deficiency cellular model 133
Curcumin and inflammatory bowel disease: Potential andlimits of innovative treatments 131
Classical and Innovative Evidence for Therapeutic Strategies in Retinal Dysfunctions 130
Defect in mevalonate pathway induces pyroptosis in Raw 264.7 murine monocytes 127
Lovastatin induces apoptosis through the mitochondrial pathway in an undifferentiated SH-SY5Y neuroblastoma cell line 126
Microglia activation and interaction with neuronal cells in a biochemical model of mevalonate kinase deficiency 120
Presence of IL-9 in paired samples of human colostrum and transitional milk 118
Advantage of First-Line Therapeutic Drug Monitoring-Driven Use of Infliximab for Treating Acute Intestinal and Liver GVHD in Children: A Prospective, Single-Center Study 116
Inflammatory bowel disease and patterns of volatile organic compounds in the exhaled breath of children: A case-control study using Ion Molecule Reaction-Mass Spectrometry 113
Prenylation Defects and Oxidative Stress Trigger the Main Consequences of Neuroinflammation Linked to Mevalonate Pathway Deregulation 112
Temperature and Drug Treatments in Mevalonate Kinase Deficiency: An Ex Vivo Study 109
Inflammation profile of four early onset Crohn patients 105
Serum amyloid A and cholesterol: a pivotal role on inflammation 104
Specific protein profile in cerebrospinal fluid from HIV-1-positive cART-treated patients affected by neurological disorders 103
Monocyte-predominant engraftment, cytokine levels and early transplant-related complications in pediatric hematopoietic stem cell recipients 101
The farnesyltransferase inhibitors tipifarnib and lonafarnib inhibit cytokines secretion in a cellular model of mevalonate kinase deficiency 100
MitoQ is able to modulate apoptosis and inflammation 99
Mevalonate kinase deficiency and IBD: shared genetic background 98
Decreased cholesterol levels reflect a consumption of anti-inflammatory isoprenoids associated with an impaired control of inflammation in a mouse model of mevalonate kinase deficiency 97
Natural isoprenoids inhibit LPS-induced-production of cytokines and nitric oxide in aminobisphosphonate-treated monocytes 96
New Mechanisms in Autoinflammatory Diseases 96
Defibrotide impact on the acute GVHD disease incidence in pediatric hematopoietic stem cell transplant recipients 94
Mouse model of mevalonate kinase deficiency: comparison of cytokines and chemokines profile with human patients 93
Clarification of the pleiotropic effects of statins on mevalonate pathway and the feedback regulation of isoprenoids requires more comprehensive investigation 93
New Applications of JAK/STAT Inhibitors in Pediatrics: Current Use of Ruxolitinib 91
Mevalonate Kinase Deficiency and Squalene Synthase Inhibitor (TAK-475): The Balance to Extinguish the Inflammation 90
Evolutionary hypothesis of the Mevalonate Kinase Deficiency 86
The Challenge of Next Generation Sequencing in a Boy with Severe Mononucleosis and EBV-related Lymphoma 86
Letter to the editor: acute effects of intravenous administration of pamidronate in patients with osteoporosis 85
Targeting farnesyl-transferase as a novel therapeutic strategy for mevalonate kinase deficiency: In vitro and in vivo approaches 83
Farnesyl and geranylgeranyl transferase inhibitors: an anti-inflammatory effect. Comment to "Inhibition of protein geranylgeranylation and farnesylation protects against graft-versus-host disease via effects on CD4 effector T cells" Haematologica. 2013;98(1):31-40 82
Letter: inflammatory bowel disease, complementary and alternative medicine, and genetics 77
Lysozyme-containing chitosan-coated arginate microspheres for oral immunisation 76
Geraniol rescues inflammation in cellular and animal models of mevalonate kinase deficiency 74
Editorial: Advances in stem cell therapy: new applications and innovative therapeutic approaches 72
Trained Immunity and Its Potential Implications in the Etiopathogenesis of Hidradenitis Suppurativa: A New Paradigm in Chronic Inflammation? 72
Post-irradiation hyperamylasemia is a prognostic marker for allogeneic hematopoietic stem cell transplantation outcomes in pediatric population: A retrospective single-centre cohort analysis 72
Standard treatment–refractory cytomegalovirus encephalitis unmasked by immune reconstitution inflammatory syndrome and successfully treated with virus-specific hyperimmune globulin 65
MIF plasma level as a possible tool to predict steroid responsiveness in children with idiopathic nephrotic syndrome 64
Long non-coding RNA GAS5 and intestinal MMP2 and MMP9 expression: A translational study in pediatric patients with IBD 60
Mevalonate kinase deficiency: Disclosing the role of mevalonate pathway modulation in inflammation 59
Systemic and neuronal inflammatory markers in a mouse model of mevalonate kinase deficiency: a strain-comparative study 53
Microcapsule a doppio strato di polisaccaridiutilizzabili come veicoli per la somministrazione oraledi sostanze biologicamente attive 53
Family history in early-onset inflammatory bowel disease 50
Phytocompounds in Precision Dermatology: COX-2 Inhibitors as a Therapeutic Target in Atopic-Prone Skin 44
Towards defining the chemical signature of inflammatory skin conditions: an in vitro model 27
Targeting Intestinal Permeability for Graft-versus-Host Disease Treatment: A Therapeutic Perspective with Defibrotide 21
TOWARDS DEFINING THE CHEMICAL SIGNATURE OF INFLAMMATORY SKIN CONDITIONS USING VOLATILE METABOLITES: AN IN VITRO MODEL 21
Totale 11.029
Categoria #
all - tutte 60.369
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 60.369


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021310 0 0 0 0 0 0 0 0 0 202 41 67
2021/2022485 37 36 15 12 11 49 41 40 20 71 22 131
2022/2023310 85 9 19 14 15 24 14 17 47 4 43 19
2023/2024373 33 38 28 9 32 22 20 22 16 20 18 115
2024/20251.776 27 37 168 67 218 158 56 67 266 316 279 117
2025/20265.011 422 388 474 766 720 288 484 332 517 620 0 0
Totale 11.029